About the Webinar
What is ERG?
Electroretinography (ERG) testing has been established as one of the earliest indicators of eye disease, showing functional stress due to glaucoma and diabetic retinopathy well before damage appears on structural imaging.
ERG Technology Is Advancing
And the technology for ERG testing has continued to progress. Today’s ERG testing with the handheld RETeval device is rapid, efficient, and easy to interpret. And working it into a busy practice has never been easier. The RETeval Device requires no corneal electrode. Instead, it uses patented electrode sensor strips. What’s more, dynamic pupillometry allows the RETeval device to work on dilated and undilated patients alike, with a color-coded reference set for straightforward report interpretation.
Optimizing Patient Outcomes
ABOUT the presenter
DR. ERNESTO L. COLLAZO, MD, FAAO
Dr. Ernesto Collazo is a graduate of New York University School of Medicine. He completed an Ophthalmology Research Fellowship at the University of Pennsylvania and an Ophthalmology Residency at Hahnemann University Hospital in Philadelphia.
In 1993, while at Hahnemann, he was selected as Chief Resident by the Department of Ophthalmology and was honored with the prestigious “Resident of the Year Award” by the Department of Surgery.
Dr. Collazo was recently showcased by Newsweek Magazine as on of the 15 leaders in laser eye surgery in the United States. This prestigious recognition is awarded to physicians who are internationally recognized for their commitment to excellence in ocular surgery and their leadership in the use of the most advanced technology.
He has also been honored on multiple occasions with the “Doctor’s Choice Awards”, having been selected by his fellow physicians as one of the best ophthalmologists in Puerto Rico.
He has been a guest lecturer for medical and non-medical organizations in the United States, Puerto Rico and Europe. He is a diplomate of the American Board of Ophthalmology and a Fellow of the American Academy of Ophthalmology.